Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.0, indicating a background update to the site template.
    Difference
    0.0%
    Check dated 2026-06-30T11:39:29.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a recruitment status update indicating no longer looking for participants, and introduced several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). Updated header text for Intervention/Treatment and revised the site revision tag from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-16T00:56:33.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a new version of the page.
    Difference
    0.0%
    Check dated 2026-06-09T01:31:19.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page. This update is at the metadata level and does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-18T13:34:20.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T07:46:59.000Z thumbnail image
  7. Check
    100 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck to the conditions and included the Genetic and Rare Diseases Information Center as a new resource.
    Difference
    0.1%
    Check dated 2026-03-29T13:00:22.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.